Myopic regression after laser in situ keratomileusis: a medical alternative to surgical enhancement.
Weiss
Jayne S
JS
Mokhtarzadeh
Maryam
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D003315:Cornea / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D020731:Keratomileusis, Laser In Situ; D054018:Lasers, Excimer; D009216:Myopia / Q000188:drug therapy* / Q000503:physiopathology; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011183:Postoperative Complications; D011412:Propanolamines / Q000008:administration & dosage*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; C036089:nipradilol